These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24163149)

  • 21. Rosuvastatin improves plaque morphology in cerebral embolism patients with normal low-density lipoprotein and severe aortic arch plaque.
    Kaneko K; Saito H; Takahashi T; Kiribayashi N; Omi K; Sasaki T; Niizeki T; Sugawara S; Akasaka M; Kubota I
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1682-9. PubMed ID: 24739590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy analysis of the lipid-lowering and renoprotective effects of rosuvastatin in patients with chronic kidney disease.
    Abe M; Maruyama N; Yoshida Y; Ito M; Okada K; Soma M
    Endocr J; 2011; 58(8):663-74. PubMed ID: 21670545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of candesartan and rosuvastatin on CD40 and MMPs expression in apo-E knockout mice: novel insights into the role of RAS and dyslipidemia in atherogenesis.
    Chen J; Li D; Schaefer RF; Mehta JL
    J Cardiovasc Pharmacol; 2004 Oct; 44(4):446-52. PubMed ID: 15454852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors involved in rosuvastatin induction of insulin sensitization in rats fed a high fat diet.
    de las Heras N; Valero-Muñoz M; Ballesteros S; Gómez-Hernández A; Martín-Fernández B; Blanco-Rivero J; Cachofeiro V; Benito M; Balfagón G; Lahera V
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1107-14. PubMed ID: 23434394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is rosuvastatin really a more efficient therapeutic option than atorvastatin?
    Soto J; Fernandez de Bobadilla J
    Value Health; 2006; 9(4):276-7; author reply 277-9. PubMed ID: 16903999
    [No Abstract]   [Full Text] [Related]  

  • 26. C-reactive protein lowering with rosuvastatin in the METEOR study.
    Peters SA; Palmer MK; Grobbee DE; Crouse JR; O'Leary DH; Raichlen JS; Bots ML
    J Intern Med; 2010 Aug; 268(2):155-61. PubMed ID: 20412373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.
    Bullano MF; Wertz DA; Yang GW; Kamat S; Borok GM; Gandhi S; McDonough KL; Willey VJ
    Pharmacotherapy; 2006 Apr; 26(4):469-78. PubMed ID: 16553504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rosuvastatin reduces intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease: the Asymptomatic Carotid Atherosclerotic Disease in Manfredonia (ACADIM) Study.
    Riccioni G; Bazzano LA; Bucciarelli T; Mancini B; di Ilio E; D'Orazio N
    Expert Opin Pharmacother; 2008 Oct; 9(14):2403-8. PubMed ID: 18778179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rosuvastatin changes cytokine expressions in ischemic territory and preserves heart function after acute myocardial infarction in rats.
    Hu X; Sun A; Xie X; Huang Z; Jia J; Yao R; Ge J
    J Cardiovasc Pharmacol Ther; 2013 Mar; 18(2):162-76. PubMed ID: 23139358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of rosuvastatin versus atorvastatin on rho-associated coiled-coil containing protein kinase activity and endothelial function in patients with atherosclerosis.
    Liu B; Cao HM; Li GY; Liu M; Feng J; Li J; Wang Q
    J Int Med Res; 2011; 39(6):2314-22. PubMed ID: 22289549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. JUPITER strikes earth.
    Fuster V; Bansilal S
    Nat Clin Pract Cardiovasc Med; 2009 Mar; 6(3):159. PubMed ID: 19234496
    [No Abstract]   [Full Text] [Related]  

  • 32. Rosuvastatin attenuates the elevation in blood pressure induced by overexpression of human C-reactive protein.
    Li X; Yang G; Zhao G; Wu B; Edin ML; Zeldin DC; Wang DW
    Hypertens Res; 2011 Jul; 34(7):869-75. PubMed ID: 21562509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining rosuvastatin with angiotensin-receptor blockers of different PPARγ-activating capacity: effects on high-density lipoprotein subfractions and associated enzymes.
    Rizos CV; Liberopoulos EN; Tellis K; DiNicolantonio JJ; Tselepis AD; Elisaf MS
    Angiology; 2015 Jan; 66(1):36-42. PubMed ID: 24288364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin.
    Satoh M; Tabuchi T; Itoh T; Nakamura M
    Clin Sci (Lond); 2014 Feb; 126(3):233-41. PubMed ID: 23944632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rosuvastatin-regulated post-translational phosphoproteome in human umbilical vein endothelial cells.
    Huang B; Wu CH; Li FA; Liang SS; Shieh YH; Wang LD
    Kaohsiung J Med Sci; 2013 Jul; 29(7):347-52. PubMed ID: 23768697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abstracts of the XV International Symposium on Drugs Affecting Lipid Metabolism, 24-27 October, 2004, Venice, Italy.
    Int J Clin Pract Suppl; 2005 Jun; (148):3-16. PubMed ID: 15885073
    [No Abstract]   [Full Text] [Related]  

  • 38. Rosuvastatin may modulate insulin signaling and inhibit atherogenesis beyond its plasma cholesterol-lowering effect in insulin-resistant mice.
    Guo H; Lv H; Tang W; Chi J; Liu L; Xu F; Ji Z; Zhai X; Peng F
    Cardiovasc Drugs Ther; 2012 Oct; 26(5):375-82. PubMed ID: 22918601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of rosuvastatin on myeloperoxidase levels in patients with chronic heart failure: a randomized placebo-controlled study.
    Andreou I; Tousoulis D; Miliou A; Tentolouris C; Zisimos K; Gounari P; Siasos G; Papageorgiou N; Papadimitriou CA; Dimopoulos MA; Stefanadis C
    Atherosclerosis; 2010 May; 210(1):194-8. PubMed ID: 19962701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rosuvastatin: a new inhibitor of HMG-coA reductase for the treatment of dyslipidemia.
    Rosenson RS
    Expert Rev Cardiovasc Ther; 2003 Nov; 1(4):495-505. PubMed ID: 15030249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.